Medicare to cover GLP-1 weight-loss meds in 18-month pilot with $50 copay
TL;DR Summary
Beginning Wednesday, Medicare will temporarily cover GLP-1 weight-loss drugs for seniors and certain disabled beneficiaries through an 18-month pilot, with a $50 monthly copay; coverage requires prior authorization and the program’s costs to taxpayers have not been disclosed. Covered drugs include Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy (including the Wegovy pill Foundayo). The move aims to curb obesity-related health risks but raises questions about long-term affordability and access.
- Medicare is about to cover GLP-1 drugs for weight loss. Here’s what to know. The Washington Post
- Medicare will start covering weight-loss drugs on July 1 for the first time. Here’s what you need to know CNN
- Medicare will help pay for weight-loss drugs Wegovy, Zepbound. What to know USA Today
- Seniors in Medicare are about to get landmark obesity drug coverage — but many may not know it yet CNBC
- Medicare to Cover GLP-1 Weight-Loss Drugs For $50 a Month: See If You’re Eligible TODAY.com
Reading Insights
Total Reads
0
Unique Readers
4
Time Saved
20 min
vs 21 min read
Condensed
98%
4,053 → 69 words
Want the full story? Read the original article
Read on The Washington Post